April 15 (Reuters) - Acrux Ltd (ACR) : US FDA HAS ACCEPTED FOR REVIEW ACRUX'S ABBREVIATED NEW DRUG APPLICATION FOR ITS GENERIC VERSION OF DAPSONE GEL
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution